The Indian supplements market is anticipated to reach $57 billion by 2030, driven by consumer awareness and lifestyle diseases, attracting major firms. However, the author critically highlights FSSAI's lenient regulations, which have led to a surge in brands but pose significant safety risks. The text strongly advocates for India to establish a dedicated regulatory body with stringent quality standards, robust product registration, and ingredient scrutiny. This is crucial to prevent adulteration, ensure consumer safety, and manage the market's rapid expansion and consolidation effectively, addressing current regulatory gaps.